CROSSJECT Email Formats

Pharmaceutical Manufacturing • Dijon, Bourgogne-Franche-Comté, France • 51-100 Employees

CROSSJECT Email Formats

CROSSJECT uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@crossject.com), used 88.7% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@crossject.com	88.7%
{first initial}.{last name}	j.doe@crossject.com	8.1%
{last name}.{first initial}	doe.j@crossject.com	1.6%
{last name}.{last name}	doe.doe@crossject.com	1.6%

Key Contacts at CROSSJECT

Olivier Lacombe

Director - Pharmaceutical Development

Isabelle Liebschutz

Quality & Regulatory Director / Qualified Person

Company overview

Headquarters	Parc MAZEN-SULLY, 6-8 rue Pauline Kergomard, Dijon, Bourgogne 21000, FR
Phone number	+33380549850
Website	crossject.com
NAICS	3254
SIC	283
Keywords	Injection Sans Aiguile And Traitements D'Urgence
Founded	2001
Employees	51-100
Socials

About CROSSJECT

Crossject SA (Euronext: ALCJ; www.crossject.com) is an emerging specialty pharma company based in France and the U.S. It is in advanced regulatory development for ZEPIZURE®, an epileptic rescue therapy, for which it was awarded a $60 million contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA). ZEPIZURE® is based on the Company’s award-winning needle-free autoinjector ZENEO®, designed to enable patients and untrained caregivers to easily and instantly deliver emergency medication via intramuscular injection on bare skin or even through clothing. The Company’s other products in development include rescue therapies for allergic shocks, adrenal insufficiencies, opioid overdose and asthma attacks.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Director

Employees by Department

CROSSJECT has 45 employees across 10 departments.

Departments

Number of employees

Funding Data

Explore CROSSJECT's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2024-03-27	16	$7,600,000
2024-08-10	16	$7,500,000
2025-01-11	14	$7,600,000
2025-07-24	14	$6,600,000
2025-10-22	16	$880,100

Funding Insights

$30,180,100

Total funding amount

$880,100

Most recent funding amount

Number of funding rounds

CROSSJECT Tech Stack

Discover the technologies and tools that power CROSSJECT's digital infrastructure, from frameworks to analytics platforms.

Autoptimize

Performance

reCAPTCHA

Security

Underscore.js

JavaScript libraries

ElementsKit

WordPress plugins

Slick

JavaScript libraries

Site Kit

Analytics

HTTP/2

Miscellaneous

WP Rocket

Caching

Drupal

CMS

jQuery UI

JavaScript libraries

Google Maps

Maps

Hello Elementor

WordPress themes

Frequently asked questions

CROSSJECT is located in Dijon, Bourgogne-Franche-Comté, FR.

You can reach CROSSJECT at +33380549850.

CROSSJECT was founded in 2001, making it 25 years old. The company has established itself as a significant player in its industry over this time.

CROSSJECT has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

CROSSJECT has raised a total of $30,180,100 across 5 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at CROSSJECT

Olivier Lacombe

Director - Pharmaceutical Development

Isabelle Liebschutz

Quality & Regulatory Director / Qualified Person

4.8

40,000 users